Tag: Drug Delivery Technology Market

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Drug Delivery Systems Market Set To Climb From $47.54 Billion In 2026 To $62.89 Billion By 2030

The drug delivery systems market has shown strong growth over recent years. It is projected to grow from $44.21 billion in 2025 to $47.54 billion in 2026, at a compound annual growth rate (CAGR) of 7.5%. The historical expansion can be attributed to the widespread use of conventional oral and injectable delivery, limited biologics formulations, the development of hospital and clinical infrastructure, the rising prevalence of chronic diseases, and increasing research and development in pharmaceuticals.

The drug delivery systems market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $62.89 billion, exhibiting a compound annual growth rate (CAGR) of 7.2%. This projected growth during the forecast period can be attributed to several factors, including advancements in polymer and lipid-based delivery systems, the expansion of personalized medicine, the increasing application of inhalation and transmucosal delivery methods, the growing acceptance of homecare and self-administration devices, and the incorporation of digital monitoring and intelligent delivery technologies. Key trends expected within this period involve the increasing uptake of targeted and controlled drug release technologies, the expanding development of biologics and advanced therapeutics, the proliferation of homecare drug delivery solutions, the advancement of minimally invasive and needle-free delivery systems, and an elevated emphasis on patient compliance and safety.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=48288219&type=smp&name=Drug%20Delivery%20Systems%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Drug Delivery Systems Market Opportunity Drivers: What’s Unlocking New Revenue Potential?

The rising occurrence of respiratory conditions is projected to drive the expansion of the drug delivery systems market in the future. Respiratory disorders are health issues that impede the normal functioning of the lungs and airways, leading to difficulty in breathing and reduced oxygen intake. The increase in these disorders is attributed to growing air pollution, which constantly exposes populations to toxic airborne particles and gases that impair lung function and contribute to the development and worsening of respiratory conditions. Drug delivery systems are essential for the effective treatment and management of respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These systems ensure that medications reach the lungs directly, thereby enhancing therapeutic outcomes while minimizing systemic side effects. For instance, in March 2025, the UK Health Security Agency, a UK-based government agency, reported that in 2024, tuberculosis cases in England climbed by 13%, increasing to 5,480 cases from 4,850 cases in 2023. This escalating prevalence of respiratory disorders is therefore expected to boost the growth of the drug delivery systems market.

Drug Delivery Systems Market Segment Analysis And Revenue Potential

The drug delivery systems market covered in this report is segmented –

1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System

2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems

3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications

4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories

Subsegments:

1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors

2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations

3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays

4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery

Drug Delivery Systems Market Innovation Trends Shaping Future Development

Leading companies within the drug delivery systems market are concentrating on developing advanced solutions, such as metal-free, multidose nasal spray pumps, to enhance user comfort and ease of handling. These metal-free, multidose nasal spray pumps are devices specifically engineered to dispense multiple doses of medication through the nasal passage without incorporating any metal components, thereby ensuring both safety and compatibility with various formulations. For example, in January 2023, Aptar Pharma, a US-based pharmaceutical company, introduced the APF Futurity metal-free, multidose nasal spray pump. This particular nasal spray pump is designed for delivering nasal saline and other similar over-the-counter products, with a significant emphasis on its recyclability. It represents the first highly recyclable nasal spray pump from Aptar Pharma, having secured a Class AA certification from cyclos-HTP for European recycling systems. Being manufactured entirely from polyolefin materials and free from metal components or recycling contaminants, it aids in streamlining recycling efforts and improving the quality of recyclates. Leveraging Aptar Pharma’s Advanced Preservative Free technology, this metal-free pump provides precise and consistent dosing with a gentle operation, without sacrificing ease of use or overall effectiveness.

Drug Delivery Systems Market Company Landscape And Competitive Strategy

Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., Tandem Diabetes Care, Pacira Biosciences Inc., Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., West Pharmaceutical Services Inc., Catalent Inc., Recipharm AB

View The Full Drug Delivery Systems Market Report:

https://thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Drug Delivery Systems Market Largest Region: Which Geography Holds The Biggest Share?

North America was the largest region in the drug delivery system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Drug Delivery Systems Market Be By 2030 Compared To Its 2026 Market Size?

The drug delivery systems market size has seen substantial growth in recent years. It is projected to expand from $44.21 billion in 2025 to $47.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. The historical growth of this market can be attributed to factors such as the reliance on conventional oral and injectable delivery methods, limited biologics formulations, the expansion of hospital and clinical infrastructure, an increasing prevalence of chronic diseases, and rising research and development in pharmaceuticals.

The drug delivery systems market size is projected to experience significant expansion in the coming years. It is anticipated to grow to $62.89 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This growth during the forecast period is attributable to advancements in polymer and lipid-based delivery systems, the expansion of personalized medicine, increased utilization of inhalation and transmucosal delivery, the rising adoption of homecare and self-administration devices, and the integration of digital monitoring and smart delivery technologies. Prominent trends for the forecast period include the increasing uptake of targeted and controlled drug release technologies, the escalating development of biologics and advanced therapeutics, a rise in homecare drug delivery solutions, the proliferation of minimally invasive and needle-free delivery systems, and an enhanced focus on patient compliance and safety.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24523&type=smp

Which Key Factors Are Driving The Drug Delivery Systems Market Growth?

The escalating occurrence of respiratory ailments is projected to drive the expansion of the drug delivery systems market in the future. These ailments are medical conditions that impede the normal operation of the lungs and respiratory passages, resulting in labored breathing and diminished oxygen absorption. The surge in respiratory disorders is attributed to rising air pollution, which consistently exposes individuals to harmful airborne particles and gases that impair lung function and contribute to the onset and aggravation of respiratory conditions. Drug delivery systems play a vital role in the effective treatment and management of various respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These sophisticated systems ensure that medications are precisely administered to the lungs, thereby improving therapeutic efficacy and reducing adverse systemic reactions. For example, in March 2025, the UK Health Security Agency, a government body based in the UK, reported a 13% increase in tuberculosis cases in England in 2024, reaching 5,480 cases, up from 4,850 cases in 2023. Consequently, the growing incidence of respiratory disorders is expected to stimulate the growth of the drug delivery systems market.

What Are The Different Segment Types In The Drug Delivery Systems Market Segment Breakdown?

The drug delivery systems market covered in this report is segmented –

1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System

2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems

3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications

4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories

Subsegments:

1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors

2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations

3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays

4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery

Which Trends Are Guiding The Direction Of The Drug Delivery Systems Market?

Major companies operating in the drug delivery systems market are concentrating on developing advanced solutions, including metal-free, multidose nasal spray pumps, to enhance user comfort and ease of handling. Metal-free, multidose nasal spray pumps are devices crafted to dispense multiple doses of medication through the nasal passage without using any metal components, thereby ensuring safety and compatibility with various formulations. For example, in January 2023, Aptar Pharma, a US-based pharmaceutical company, unveiled the APF Futurity metal-free, multidose nasal spray pump. This nasal spray pump is specifically engineered for delivering nasal saline and comparable over-the-counter products, with a strong emphasis on recyclability. It represents Aptar Pharma’s first highly recyclable nasal spray pump, having achieved a Class AA certification from cyclos-HTP for European recycling systems. Constructed entirely from polyolefin materials and free of metal components or recycling contaminants, it helps streamline recycling processes and improve the quality of recyclate. Utilizing Aptar Pharma’s Advanced Preservative Free technology, this metal-free pump ensures precise and consistent dosing with gentle operation, without compromising on ease of use or effectiveness.

Who Are The Well-Known Companies In The Drug Delivery Systems Market?

Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., Tandem Diabetes Care, Pacira Biosciences Inc., Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., West Pharmaceutical Services Inc., Catalent Inc., Recipharm AB

Get The Full Drug Delivery Systems Market Report:

https://www.thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report

Which Region Is The Leading Market For The Drug Delivery Systems Market?

North America was the largest region in the drug delivery system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Drug Delivery Systems Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=24523&type=smp

Browse Through More Reports Similar to the Global Drug Delivery Systems Market 2026, By The Business Research Company

Advanced Drug Delivery Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/advanced-drug-delivery-systems-global-market-report

Electronic Drug Delivery Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-drug-delivery-systems-global-market-report

Gastroretentive Drug Delivery Systems Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Drug Delivery Systems Market Projected To Become By 2030 Based On Its 2026 Valuation?

The drug delivery systems market has experienced robust expansion over the past few years. This market is projected to expand from $44.21 billion in 2025 to $47.54 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.5%. Historically, this growth was primarily driven by factors such as the significant dependence on traditional oral and injectable delivery methods, constraints in biologics formulations, the expansion of hospital and clinical facilities, an increase in the prevalence of chronic diseases, and heightened pharmaceutical research and development.

The drug delivery systems market size is projected to undergo significant expansion over the next few years. It is expected to reach $62.89 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This projected growth during the forecast period is fueled by advancements in polymer and lipid-based delivery systems, the expansion of personalized medicine, a rise in the use of inhalation and transmucosal delivery methods, increasing adoption of homecare and self-administration devices, and the integration of digital monitoring alongside smart delivery technologies. Prominent developments anticipated in this period encompass the growing acceptance of targeted and controlled drug release technologies, an increase in the development of biologics and advanced therapeutics, the growth of homecare drug delivery solutions, the expansion of minimally invasive and needle-free delivery systems, and an enhanced focus on patient compliance and safety.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24523&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Drug Delivery Systems Market?

The rising occurrence of respiratory conditions is expected to drive expansion in the drug delivery systems market in the coming years. These disorders are defined as ailments that hinder the proper operation of the lungs and air passages, resulting in labored breathing and lower oxygen absorption. The surge in respiratory ailments is linked to escalating air pollution, constantly exposing people to harmful airborne matter and gases that damage lung function and exacerbate these conditions. Drug delivery mechanisms play a vital role in the effective treatment and management of various respiratory illnesses, including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These methods guarantee that medicines are administered straight to the lungs, thereby improving treatment results and reducing adverse systemic reactions. As an illustration, the UK Health Security Agency, a government body based in the UK, reported in March 2025 that tuberculosis instances in England saw a 13% rise in 2024, reaching 5,480 cases compared to 4,850 cases in 2023. Consequently, the growing frequency of respiratory conditions is projected to stimulate the expansion of the drug delivery systems market.

What Segment Groups Are Identified Within The Drug Delivery Systems Market?

The drug delivery systems market covered in this report is segmented –

1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System

2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems

3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications

4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories

Subsegments:

1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors

2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations

3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays

4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery

What Trends Are Advancing Progress In The Drug Delivery Systems Market?

Leading companies within the drug delivery systems market are increasingly focusing on developing sophisticated solutions, such as metal-free, multidose nasal spray pumps, to enhance user comfort and ease of handling. These specific pumps are devices designed to deliver multiple medication doses through the nasal passage, completely without metal components, thus ensuring safety and compatibility with various formulations. For instance, in January 2023, Aptar Pharma, a US-based pharmaceutical company, introduced the APF Futurity metal-free, multidose nasal spray pump. This particular nasal spray pump is engineered for dispensing nasal saline and similar over-the-counter products, with a significant emphasis on its recyclability. It stands as Aptar Pharma’s first highly recyclable nasal spray pump, having secured a Class AA certification from cyclos-HTP for European recycling systems. Being manufactured entirely from polyolefin materials and devoid of metal components or recycling contaminants, it aids in streamlining recycling efforts and improving the quality of recyclates. Leveraging Aptar Pharma’s Advanced Preservative Free technology, this metal-free pump guarantees precise and consistent dosing coupled with gentle operation, without sacrificing ease of use or overall effectiveness.

Which Companies Hold Significant Positions In The Drug Delivery Systems Market?

Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., Tandem Diabetes Care, Pacira Biosciences Inc., Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., West Pharmaceutical Services Inc., Catalent Inc., Recipharm AB

Read the full drug delivery systems market report here:

https://www.thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report

Which Regions Are Projected To Dominate The Drug Delivery Systems Market In The Coming Years?

North America was the largest region in the drug delivery system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Drug Delivery Systems Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24523&type=smp

Browse Through More Reports Similar to the Global Drug Delivery Systems Market 2026, By The Business Research Company

Advanced Drug Delivery Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/advanced-drug-delivery-systems-global-market-report

Electronic Drug Delivery Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-drug-delivery-systems-global-market-report

Gastroretentive Drug Delivery Systems Outsourcing Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

How is the Drug Delivery Systems Market size predicted to change over the forecast window of 2026–2035?

The drug delivery systems market has seen robust growth over recent years. It is anticipated to expand from $44.21 billion in 2025 to $47.54 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.5%. The expansion witnessed in the past can be ascribed to several factors, including a reliance on conventional oral and injectable delivery methods, the limited range of biologics formulations, an increase in hospital and clinical infrastructure, the rising prevalence of chronic diseases, and growing research and development in pharmaceuticals.

The drug delivery systems market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $62.89 billion by 2030, progressing at a compound annual growth rate (CAGR) of 7.2%. This expected growth during the forecast period stems from developments in polymer and lipid-based delivery systems, the expansion of personalized medicine, a greater reliance on inhalation and transmucosal delivery methods, the growing acceptance of homecare and self-administration devices, and the incorporation of digital monitoring and intelligent delivery technologies. Prominent trends for the forecast period encompass the increasing adoption of targeted and controlled drug release technologies, a surge in the development of biologics and advanced therapeutics, an increase in homecare drug delivery solutions, the broadening use of minimally invasive and needle-free delivery systems, and a heightened focus on ensuring patient compliance and safety.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24523&type=smp

Which Drivers Are Contributing To The Expansion Of The Drug Delivery Systems Market?

The drug delivery systems market is projected to expand in the future, driven by the growing incidence of respiratory ailments. These disorders are conditions that hinder the regular operation of the lungs and airways, resulting in impaired breathing and lower oxygen absorption. The increase in respiratory disorders stems from escalating air pollution, which consistently exposes individuals to harmful airborne substances and gases that damage lung function and exacerbate these conditions. Drug delivery systems play a crucial role in the effective treatment and management of various respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These mechanisms ensure the direct administration of medications to the lungs, thereby improving therapeutic results and reducing systemic adverse effects. For example, the UK Health Security Agency, a UK-based government body, reported in March 2025 that tuberculosis cases in England saw a 13% increase in 2024, reaching 5,480 cases from 4,850 cases in 2023. Consequently, the rising occurrence of respiratory illnesses will significantly propel the drug delivery systems market’s expansion.

What Segment Classifications Make Up The Drug Delivery Systems Market?

The drug delivery systems market covered in this report is segmented –

1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System

2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems

3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications

4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories

Subsegments:

1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors

2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations

3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays

4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery

Which Innovation Trends Are Advancing Developments Within The Drug Delivery Systems Market?

Companies operating within the drug delivery systems market are prioritizing the creation of sophisticated solutions, such as metal-free, multidose nasal spray pumps, aimed at enhancing user comfort and simplifying handling. These metal-free, multidose nasal spray pumps are devices specifically designed to administer multiple medication doses via the nasal passage without incorporating any metal components, thereby guaranteeing safety and compatibility across diverse formulations. For instance, in January 2023, Aptar Pharma, a US-based pharmaceutical company, unveiled its APF Futurity metal-free, multidose nasal spray pump. This particular nasal spray pump is designed for dispensing nasal saline and various other over-the-counter products, with a significant emphasis on its recyclability. It stands as the inaugural highly recyclable nasal spray pump from Aptar Pharma, having achieved a Class AA certification from cyclos-HTP for European recycling systems. Composed entirely of polyolefin materials and devoid of metal parts or recycling contaminants, it contributes to streamlined recycling processes and improves the quality of recyclate. Leveraging Aptar Pharma’s Advanced Preservative Free technology, this metal-free pump guarantees accurate and consistent dosing with gentle operation, all without compromising ease of use or overall effectiveness.

Which Key Market Players Are Investing In Expansion And Innovation Within The Drug Delivery Systems Market?

Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., Tandem Diabetes Care, Pacira Biosciences Inc., Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., West Pharmaceutical Services Inc., Catalent Inc., Recipharm AB

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Drug Delivery Systems Market?

North America was the largest region in the drug delivery system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Drug Delivery Systems Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24523&type=smp

Browse Through More Reports Similar to the Global Drug Delivery Systems Market 2026, By The Business Research Company

Advanced Drug Delivery Systems Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/advanced-drug-delivery-systems-global-market-report

Electronic Drug Delivery Systems Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/electronic-drug-delivery-systems-global-market-report

Gastroretentive Drug Delivery Systems Outsourcing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Drug Delivery Systems Market Covering 2025–2034?

The drug delivery systems market has witnessed significant expansion in recent years. This market is set to increase from $41.17 billion in 2024 to $44.21 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.4%. The historical growth trajectory is primarily due to escalating research and development investments, a rise in the prevalence of chronic diseases, the proliferation of biologics and monoclonal antibodies, substantial demand for non-invasive delivery methods, and the ongoing requirement for better patient compliance and adherence.

The drug delivery systems market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $58.64 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast timeframe is primarily driven by factors such as an increasing emphasis on personalized medicine, a widening array of complex and sensitive drugs under development, the escalating incidence of rare and orphan diseases, supportive regulatory frameworks for novel delivery systems, and an aging global populace. Key developments expected within this period encompass the creation of nanotechnology-enabled drug delivery mechanisms, advancements in controlled-release and sustained-release methods, progress in biologics and biosimilars necessitating specific administration techniques, the incorporation of intelligent drug delivery devices, and the formulation of targeted delivery systems specifically for cancer treatment.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24523&type=smp

What Are The Drivers Pushing New Developments In The Drug Delivery Systems Market?

The increasing occurrence of respiratory ailments is expected to drive the expansion of the drug delivery systems market in the future. Respiratory disorders are conditions that disrupt the normal operation of the lungs and airways, leading to labored breathing and decreased oxygen intake. The surge in respiratory disorders stems from rising air pollution, which persistently exposes populations to toxic airborne particles and gases that compromise lung function and contribute to the onset and worsening of respiratory conditions. Drug delivery systems play a crucial role in the effective treatment and management of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These sophisticated systems guarantee that medications are delivered directly into the lungs, thereby enhancing therapeutic outcomes while simultaneously reducing systemic side effects. For instance, in March 2025, the UK Health Security Agency, a UK-based government agency, reported that tuberculosis cases in England rose by 13% in 2024, climbing to 5,480 cases from 4,850 cases in 2023. Thus, the escalating prevalence of respiratory disorders will propel the growth of the drug delivery systems market.

What Are The Major Segment Categories Driving The Drug Delivery Systems Market Growth?

The drug delivery systems market covered in this report is segmented –

1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System

2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems

3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications

4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories

Subsegments:

1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors

2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations

3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays

4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery

Which Market Trends Are Creating New Opportunities In The Drug Delivery Systems Industry?

Major companies operating in the drug delivery systems market are concentrating on developing advanced solutions, such as metal-free, multidose nasal spray pumps, to enhance user comfort and ease of handling. Metal-free, multidose nasal spray pumps are devices designed to deliver multiple doses of medication through the nasal passage without utilizing any metal components, ensuring both safety and compatibility with diverse formulations. For instance, in January 2023, Aptar Pharma, a US-based pharmaceutical company, introduced the APF Futurity metal-free, multidose nasal spray pump. This nasal spray pump is engineered for delivering nasal saline and other comparable over-the-counter products, with a strong emphasis on its recyclability. It represents Aptar Pharma’s first highly recyclable nasal spray pump, achieving a Class AA certification from cyclos-HTP for European recycling systems. Made entirely from polyolefin materials and devoid of metal components or recycling contaminants, it helps streamline recycling and improve recyclate quality. Utilizing Aptar Pharma’s Advanced Preservative Free technology, this metal-free pump ensures precise and consistent dosing with gentle operation, without compromising on ease of use or effectiveness.

Who Are The Prominent Global Companies Shaping The Drug Delivery Systems Market?

Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Tandem Diabetes, Pacira Biosciences, Poseida Therapeutics, Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., VasoRx Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report

How Is Drug Delivery Systems Market Demand Varying Across Different Regions?

North America was the largest region in the drug delivery system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Drug Delivery Systems Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24523&type=smp

Browse Through More Reports Similar to the Global Drug Delivery Systems Market 2025, By The Business Research Company

Pharmaceutical Drug Delivery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Advanced Drug Delivery Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/advanced-drug-delivery-systems-global-market-report

Electronic Drug Delivery Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electronic-drug-delivery-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Drug Delivery Systems Market Expected to Be in 2029?

The scale of the drug delivery systems market has seen a solid expansion in past years. Its growth is forecasted to rise from $41.17 billion in 2024 to $44.21 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this growth during the historical timeline include surging investments in research and development, an increase in chronic illnesses, the emergence of biologics and monoclonal antibodies, a high requirement for non-invasive delivery methods, and an imperative for better patient adherence and compliance.

The market size of drug delivery systems is predicted to experience substantial growth in the coming years, expanding to $58.64 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 7.3%. This growth during the forecast period can be ascribed to the heightened focus on personalized medicine, enlargement of complex and sensitive drug pipelines, an increasing incidence of rare and orphan diseases, supportive regulatory paths for innovative delivery systems, and a rising elderly population. Key trends anticipated in the forecast duration include the creation of nanotechnology-based drug delivery systems, breakthroughs in controlled-release and sustained-release technologies, advancements in biologics and biosimilars needing specialized delivery, the synthesis of smart drug delivery devices, and the development of targeted delivery systems for oncology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24523&type=smp

What Are The Contributors To Demand In The Drug Delivery Systems Market?

The escalating instances of respiratory issues are predicted to propel the expansion of the drug delivery systems market. With a rising trend in conditions that hinder the smooth operation of the lungs and airways, leading to breathing difficulties and insufficient oxygen intake, respiratory disorders are increasingly common. The continuous exposure of the populace to harmful airborne particles and gases due to growing air pollution is a major cause of these disorders. It harms lung functionality and aids the progression of respiratory ailments. Drug delivery systems are vital for effective treatment of respiratory diseases like asthma, COPD, pulmonary fibrosis, and cystic fibrosis. They assure that the medicine reaches the lungs directly, maximizing the therapeutic effect and minimizing side effects. As per the UK Health Security Agency, a government agency in the UK, there was a 13% surge in tuberculosis cases in England in 2024, numbering 5,480 from the 4,850 cases of 2023. Hence, the rising incidence of respiratory conditions is anticipated to push the growth of the drug delivery systems market.

What Segmentation Categories Are Included In The Drug Delivery Systems Market Analysis?

The drug delivery systems market covered in this report is segmented –

1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System

2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems

3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications

4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories

Subsegments:

1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors

2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations

3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays

4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery

What Upcoming Trends Are Expected To Impact The Drug Delivery Systems Market Globally?

Numerous key players in the drug delivery systems sector are emphasizing novel and innovative creations, such as completely metallic-free, multiple dose nasal spray pumps to enhance user comfort and manageability. These metallic-free multi-dose nasal spray pumps are contraptions designed to dispense several doses of medicine via the nose without incorporating metallic elements, which guarantees safety and compatibility with an array of formulations. For example, Aptar Pharma, a pharmaceutical business headquartered in the United States, introduced the APF Futurity, which is a metal-free, multidose nasal spray pump in January 2023. It is a nasal spray pump specifically designed for the delivery of nasal saline and other comparable over-the-counter products. The product is highly sustainable and it’s the first nasal spray pump from Aptar Pharma to garner Class AA qualification from cyclos-HTP for European recycling schemes. Constructed purely from polyolefin materials and devoid of metal elements or recycling contaminants, it simplifies recycling and enhances recyclate quality. The metal-free pump uses Aptar Pharma’s Advanced Preservative Free technology, for assured accurate and consistent dosage with a mild operation, yet maintaining ease of usage and efficacy.

Who Are The Top-Ranked Companies In The Drug Delivery Systems Market Today?

Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Tandem Diabetes, Pacira Biosciences, Poseida Therapeutics, Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., VasoRx Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report

How Is Drug Delivery Systems Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the drug delivery system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24523&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Drug Delivery Systems Market Size Changed, over the years?

In recent years, the market size for drug delivery systems has seen significant growth. It’s projected to expand from $41.17 billion in 2024 to $44.21 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. This growth during the historic period can be tied to factors such as an increase in research and development investments, a surge in chronic diseases, growth in biologics and monoclonal antibodies, a high demand for non-invasive delivery methods, as well as a need for enhanced patient compliance and adherence.

How Much Will the Drug Delivery Systems Market Be Worth in 2029?

The market for drug delivery systems is predicted to experience robust growth in the upcoming years, expanding to a worth of $58.64 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. This anticipated growth during the forecast period can be linked to the increasing emphasis on personalized medicine, a growing list of intricate and sensitive drugs in the pipeline, a rise in uncommon and orphan diseases, favorable regulatory environments for novel delivery systems, and an increasing elderly demographic. Main trends expected during this period are the formulation of drug delivery systems based on nanotechnology, advancements in controlled-release and sustained-release technologies, progress in biologics and biosimilars that need specialized delivery, incorporation of intelligent drug delivery devices, and the design of targeted delivery systems for cancer treatment.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24523&type=smp

Which is the Largest Company in the Drug Delivery Systems Market?

Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Tandem Diabetes, Pacira Biosciences, Poseida Therapeutics, Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., VasoRx Inc.

What Are the Main Market Drivers in the Drug Delivery Systems Industry?

The drug delivery systems market is expected to expand due to the growing occurrence of respiratory disorders. Respiratory disorders interfere with the standard functioning of the lungs and airways, leading to breathing difficulties and less oxygen absorption. The escalating levels of air pollution, which continuously expose people to harmful airborne particles and gases, play a part in increasing respiratory disorders, thereby impacting lung function and leading to the progression of respiratory conditions. Drug delivery systems are crucial for effectively treating and managing respiratory afflictions like asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These systems ensure that the medication is delivered directly to the lungs, thereby enhancing treatment outcomes and reducing systemic side effects. For example, the UK Health Security Agency, a government body in the UK, reported in March 2025 that tuberculosis cases in England saw a rise of 13%, from 4,850 cases in 2023 to 5,480 cases in 2024. Hence, the surge in respiratory disorders is projected to spur growth in the drug delivery systems market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24523&type=smp

How Is the Drug Delivery Systems Market Segments Structured?

The drug delivery systems market covered in this report is segmented –

1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System

2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems

3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications

4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories

Subsegments:

1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors

2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations

3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays

4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery

What Strategic Trends Are Transforming the Drug Delivery Systems Market?

Leading companies in the drug delivery systems market are now prioritizing the development of innovative solutions, such as metal-free, multidose nasal spray pumps, to enhance user comfort and ease of use. These devices have been specifically designed to administer multiple doses of medication through the patient’s nasal passage without relying on any metal parts, guaranteeing both safety and compatibility with a variety of formulations. For example, in January 2023, Aptar Pharma, a pharmaceutical firm based in the US, introduced the APF Futurity metal-free, multidose nasal spray pump. This device is meticulously designed to deliver nasal saline and other related over-the-counter items, with a great emphasis on recyclability. As Aptar Pharma’s first fully recyclable nasal spray pump, it achieved Class AA certification from cyclos-HTP for recycling systems in Europe. Its construction from purely polyolefin materials, devoid of any metal parts or pollutants that may hinder recycling, allows for efficient recycling and enhances the quality of the recyclate. By leveraging Aptar Pharma’s Advanced Preservative Free technology, this metal-free pump guarantees accurate and regular doses through a gentle process, without sacrificing ease of use or performance.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report

Which Global Regions Offer the Highest Growth in the Drug Delivery Systems Market?

North America was the largest region in the drug delivery system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24523

This Report Delivers Insight On:

1. How big is the drug delivery systems market, and how is it changing globally?

2. Who are the major companies in the drug delivery systems market, and how are they performing?

3. What are the key opportunities and risks in the drug delivery systems market right now?

4. Which products or customer segments are growing the most in the drug delivery systems market?

5. What factors are helping or slowing down the growth of the drug delivery systems market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Drug Delivery Systems Market Size Changed, over the years?

In recent years, the market size for drug delivery systems has seen significant growth. It’s projected to expand from $41.17 billion in 2024 to $44.21 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. This growth during the historic period can be tied to factors such as an increase in research and development investments, a surge in chronic diseases, growth in biologics and monoclonal antibodies, a high demand for non-invasive delivery methods, as well as a need for enhanced patient compliance and adherence.

How Much Will the Drug Delivery Systems Market Be Worth in 2029?

The market for drug delivery systems is predicted to experience robust growth in the upcoming years, expanding to a worth of $58.64 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. This anticipated growth during the forecast period can be linked to the increasing emphasis on personalized medicine, a growing list of intricate and sensitive drugs in the pipeline, a rise in uncommon and orphan diseases, favorable regulatory environments for novel delivery systems, and an increasing elderly demographic. Main trends expected during this period are the formulation of drug delivery systems based on nanotechnology, advancements in controlled-release and sustained-release technologies, progress in biologics and biosimilars that need specialized delivery, incorporation of intelligent drug delivery devices, and the design of targeted delivery systems for cancer treatment.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24523&type=smp

Which is the Largest Company in the Drug Delivery Systems Market?

Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Tandem Diabetes, Pacira Biosciences, Poseida Therapeutics, Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., VasoRx Inc.

What Are the Main Market Drivers in the Drug Delivery Systems Industry?

The drug delivery systems market is expected to expand due to the growing occurrence of respiratory disorders. Respiratory disorders interfere with the standard functioning of the lungs and airways, leading to breathing difficulties and less oxygen absorption. The escalating levels of air pollution, which continuously expose people to harmful airborne particles and gases, play a part in increasing respiratory disorders, thereby impacting lung function and leading to the progression of respiratory conditions. Drug delivery systems are crucial for effectively treating and managing respiratory afflictions like asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These systems ensure that the medication is delivered directly to the lungs, thereby enhancing treatment outcomes and reducing systemic side effects. For example, the UK Health Security Agency, a government body in the UK, reported in March 2025 that tuberculosis cases in England saw a rise of 13%, from 4,850 cases in 2023 to 5,480 cases in 2024. Hence, the surge in respiratory disorders is projected to spur growth in the drug delivery systems market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24523&type=smp

How Is the Drug Delivery Systems Market Segments Structured?

The drug delivery systems market covered in this report is segmented –

1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System

2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems

3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications

4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories

Subsegments:

1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors

2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations

3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays

4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery

What Strategic Trends Are Transforming the Drug Delivery Systems Market?

Leading companies in the drug delivery systems market are now prioritizing the development of innovative solutions, such as metal-free, multidose nasal spray pumps, to enhance user comfort and ease of use. These devices have been specifically designed to administer multiple doses of medication through the patient’s nasal passage without relying on any metal parts, guaranteeing both safety and compatibility with a variety of formulations. For example, in January 2023, Aptar Pharma, a pharmaceutical firm based in the US, introduced the APF Futurity metal-free, multidose nasal spray pump. This device is meticulously designed to deliver nasal saline and other related over-the-counter items, with a great emphasis on recyclability. As Aptar Pharma’s first fully recyclable nasal spray pump, it achieved Class AA certification from cyclos-HTP for recycling systems in Europe. Its construction from purely polyolefin materials, devoid of any metal parts or pollutants that may hinder recycling, allows for efficient recycling and enhances the quality of the recyclate. By leveraging Aptar Pharma’s Advanced Preservative Free technology, this metal-free pump guarantees accurate and regular doses through a gentle process, without sacrificing ease of use or performance.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report

Which Global Regions Offer the Highest Growth in the Drug Delivery Systems Market?

North America was the largest region in the drug delivery system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24523

This Report Delivers Insight On:

1. How big is the drug delivery systems market, and how is it changing globally?

2. Who are the major companies in the drug delivery systems market, and how are they performing?

3. What are the key opportunities and risks in the drug delivery systems market right now?

4. Which products or customer segments are growing the most in the drug delivery systems market?

5. What factors are helping or slowing down the growth of the drug delivery systems market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Drug Delivery Systems Market Size Changed, over the years?

In recent years, the market size for drug delivery systems has seen significant growth. It’s projected to expand from $41.17 billion in 2024 to $44.21 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. This growth during the historic period can be tied to factors such as an increase in research and development investments, a surge in chronic diseases, growth in biologics and monoclonal antibodies, a high demand for non-invasive delivery methods, as well as a need for enhanced patient compliance and adherence.

How Much Will the Drug Delivery Systems Market Be Worth in 2029?

The market for drug delivery systems is predicted to experience robust growth in the upcoming years, expanding to a worth of $58.64 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. This anticipated growth during the forecast period can be linked to the increasing emphasis on personalized medicine, a growing list of intricate and sensitive drugs in the pipeline, a rise in uncommon and orphan diseases, favorable regulatory environments for novel delivery systems, and an increasing elderly demographic. Main trends expected during this period are the formulation of drug delivery systems based on nanotechnology, advancements in controlled-release and sustained-release technologies, progress in biologics and biosimilars that need specialized delivery, incorporation of intelligent drug delivery devices, and the design of targeted delivery systems for cancer treatment.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24523&type=smp

Which is the Largest Company in the Drug Delivery Systems Market?

Major companies operating in the drug delivery systems market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Inc., Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Tandem Diabetes, Pacira Biosciences, Poseida Therapeutics, Universal Stabilization Technologies Inc., Spectrum Pharmaceuticals Inc., VasoRx Inc.

What Are the Main Market Drivers in the Drug Delivery Systems Industry?

The drug delivery systems market is expected to expand due to the growing occurrence of respiratory disorders. Respiratory disorders interfere with the standard functioning of the lungs and airways, leading to breathing difficulties and less oxygen absorption. The escalating levels of air pollution, which continuously expose people to harmful airborne particles and gases, play a part in increasing respiratory disorders, thereby impacting lung function and leading to the progression of respiratory conditions. Drug delivery systems are crucial for effectively treating and managing respiratory afflictions like asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis. These systems ensure that the medication is delivered directly to the lungs, thereby enhancing treatment outcomes and reducing systemic side effects. For example, the UK Health Security Agency, a government body in the UK, reported in March 2025 that tuberculosis cases in England saw a rise of 13%, from 4,850 cases in 2023 to 5,480 cases in 2024. Hence, the surge in respiratory disorders is projected to spur growth in the drug delivery systems market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24523&type=smp

How Is the Drug Delivery Systems Market Segments Structured?

The drug delivery systems market covered in this report is segmented –

1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System

2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems

3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications

4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories

Subsegments:

1) By Injection-Based Drug Delivery System: Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intradermal, Intrathecal, Depot Injections, Needle-Free Injectors

2) By Oral Drug Delivery System: Tablets, Capsules, Solutions And Syrups, Suspensions, Powders And Granules, Modified Release Formulations

3) By Inhalation Or Pulmonary Drug Delivery System: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers, Soft Mist Inhalers, Nasal Sprays

4) By Transmucosal Drug Delivery System: Buccal Delivery, Sublingual Delivery, Rectal Delivery, Vaginal Delivery, Nasal Mucosal Delivery

What Strategic Trends Are Transforming the Drug Delivery Systems Market?

Leading companies in the drug delivery systems market are now prioritizing the development of innovative solutions, such as metal-free, multidose nasal spray pumps, to enhance user comfort and ease of use. These devices have been specifically designed to administer multiple doses of medication through the patient’s nasal passage without relying on any metal parts, guaranteeing both safety and compatibility with a variety of formulations. For example, in January 2023, Aptar Pharma, a pharmaceutical firm based in the US, introduced the APF Futurity metal-free, multidose nasal spray pump. This device is meticulously designed to deliver nasal saline and other related over-the-counter items, with a great emphasis on recyclability. As Aptar Pharma’s first fully recyclable nasal spray pump, it achieved Class AA certification from cyclos-HTP for recycling systems in Europe. Its construction from purely polyolefin materials, devoid of any metal parts or pollutants that may hinder recycling, allows for efficient recycling and enhances the quality of the recyclate. By leveraging Aptar Pharma’s Advanced Preservative Free technology, this metal-free pump guarantees accurate and regular doses through a gentle process, without sacrificing ease of use or performance.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-delivery-systems-global-market-report

Which Global Regions Offer the Highest Growth in the Drug Delivery Systems Market?

North America was the largest region in the drug delivery system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24523

This Report Delivers Insight On:

1. How big is the drug delivery systems market, and how is it changing globally?

2. Who are the major companies in the drug delivery systems market, and how are they performing?

3. What are the key opportunities and risks in the drug delivery systems market right now?

4. Which products or customer segments are growing the most in the drug delivery systems market?

5. What factors are helping or slowing down the growth of the drug delivery systems market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model